Neoepitopes reveal the features of type II collagen cleavage and the identity of a collagenase involved in the transformation of the epiphyses anlagen in development

Developmental Dynamics

Volumn 238, Issue 6, 2009, Pages 1547-1563

  Lee, Eunice R ^a,b   Lamplugh, Lisa ^a   Kluczyk, Beata ^a   Leblond, Charles P ^a   Mort, John S ^a  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Angiogenesis and endothelium; Anti neoepitope antibodies; COL2; Collagen biomarkers; Collagen fragments; CTX II; MMP activation; MMP 13; MMPs; Skeletal development; Type II collagen

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN FIBRIL; COLLAGEN TYPE 2; COLLAGENASE; COLLAGENASE 3; EPITOPE; GELATINASE A; MATRIX METALLOPROTEINASE 14;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; COLLAGEN DEGRADATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME REGULATION; EPIPHYSIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

AGGRECANS; ANIMALS; ANTIBODIES; COLLAGEN TYPE II; COLLAGENASES; ENZYME ACTIVATION; EPIPHYSES; EPITOPES; ISOENZYMES; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 14; MICE; MICE, INBRED C57BL; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 66349108703     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21960     Document Type: Article

References (61)

1. Alvarez J, Costales L, Serra R, Balbin M, Lopez JM. 2005. Expression patterns of matrix metalloproteinases and vascular endothelial growth factor during epiphyseal ossification. J Bone Miner Res 20:1011-1021. (Pubitemid 40712826)
2. Atley LM, Shao P, Ochs V, Shaffer K, Eyre DR. 1998. Matrix- metalloproteinase-mediated release of immunoreactive telopeptides from cartilage type II collagen. Trans Orthop Res Soc 23:850.
3. Ballock RT, O'Keefe RJ. 2003. The biology of the growth plate. J Bone Joint Surg Am 85:715-726.
4. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR. 1997. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 99:1534-1545. (Pubitemid 27163804)
5. Charni-Ben Tabassi N, Desmarais S, Bay-Jensen AC, Delaisse JM, Percival MD, Garnero P. 2008. The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation. Osteoarthritis Cartilage 16:1183-1191.
6. Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P. 2001. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 29:209-215. (Pubitemid 32823562)
7. Chun TH, Sabeh F, Ota I, Murphy H, McDonagh KT, Holmbeck K, Birkedal-Hansen H, Allen ED, Weiss SJ. 2004. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol 167:757-767. (Pubitemid 39565155)
8. Chung L, Dinakarpandian D, Yoshida N, Lauer-Fields JL, Fields GB, Visse R, Nagase H. 2004. Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO J 23:3020-3030. (Pubitemid 39093596)
9. Cowell S, Knauper V, Stewart ML, D'Ortho MP, Stanton H, Hembry RM, Lopez-Otin C, Reynolds JJ, Murphy G. 1998. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 331(pt 2):453-458. (Pubitemid 28182159)
10. Davoli MA, Lamplugh L, Beauchemin A, Chan K, Mordier S, Mort JS, Murphy G, Docherty AJ, Leblond CP, Lee ER. 2001. Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats aged 0-21 days: II. Two proteinases, gelatinase B and collagenase-3, are implicated in the lysis of collagen fibrils. Dev Dyn 222:71-88.
11. Eyre DR, Shao P, Vosberg-Smith K, Weis M, Shaffer K, Yoshihara P. 1996. Cross-linked telopeptides from collagen types I, II and III in human urine. J Bone Miner Res 11:S413.
12. Eyre DR, Wu JJ, Fernandes RJ, Pietka TA, Weis MA. 2002. Recent developments in cartilage research: matrix biology of the collagen II/IX/XI heterofibril network. Biochem Soc Trans 30:893-899. (Pubitemid 36002375)
13. Eyre DR, Weis MA, Wu JJ. 2008. Advances in collagen cross-link analysis. Methods 45:65-74.
14. Hembry RM, Murphy G, Cawston TE, Dingle JT, Reynolds JJ. 1986. Characterization of a specific antiserum for mammalian collagenase from several species: immunolocalization of collagenase in rabbit chondrocytes and uterus. J Cell Sci 81:105-123.
15. Hipps DS, Hembry RM, Docherty AJ, Reynolds JJ, Murphy G. 1991. Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts. Biol Chem Hoppe Seyler 372:287-296.
16. Hoegh-Andersen P, Tanko LB, Andersen TL, Lundberg CV, Mo JA, Heegaard AM, Delaisse JM, Christgau S. 2004. Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. Arthritis Res Ther 6:R169-R180.
17. Holmbeck K, Szabova L. 2006. Aspects of extracellular matrix remodeling in development and disease. Birth Defects Res C Embryo Today 78:11-23. (Pubitemid 43726173)
18. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92. (Pubitemid 29468632)
19. Holmbeck K, Bianco P, Chrysovergis K, Yamada S, Birkedal-Hansen H. 2003. MT1-MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth. J Cell Biol 163:661-671. (Pubitemid 37429877)
20. Holmbeck K, Bianco P, Yamada S, Birkedal-Hansen H. 2004. MT1-MMP: a tethered collagenase. J Cell Physiol 200:11-19. (Pubitemid 38720617)
21. Holmbeck K, Bianco P, Pidoux I, Inoue S, Billinghurst RC, Wu W, Chrysovergis K, Yamada S, Birkedal-Hansen H, Poole AR. 2005. The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone. J Cell Sci 118:147-156. (Pubitemid 40277113)
22. Inada M, Wang Y, Byrne MH, Rahman MU, Miyaura C, Lopez-Otin C, Krane SM. 2004. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci U S A 101:17192-17197. (Pubitemid 39627796)
23. Ishikawa T, Nishigaki F, Christgau S, Noto T, Mo J, From N, Minoura K, Hirayama Y, Ohkubo Y, Mutoh S. 2004. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments. J Rheumatol 31:1174-1179. (Pubitemid 38715895)
24. Itoh Y. 2006. MT1-MMP: a key regulator of cell migration in tissue. IUBMB Life 58:589-596. (Pubitemid 44527223)
25. Itoh Y, Seiki M. 2006. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 206:1-8. (Pubitemid 41740711)
26. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM. 2002. Tissue origins and interactions in the mammalian skull vault. Dev Biol 241:106-116. (Pubitemid 34066765)
27. Kennedy AM, Inada M, Krane SM, Christie PT, Harding B, Lopez-Otin C, Sanchez LM, Pannett AAJ, Dearlove A, Hartley C, Byrne MH, Reed AAC, Nesbit MA, Whyte MP, Thakker RV. 2005. MMP-13 mutation causes spondylo-epimetaphyseal dysplasia, Missouri type (SEMD(MO)). J Clin Invest 115:2832-2842. (Pubitemid 41434410)
28. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. 1996a. Biochemical characterization of human collagenase-3. J Biol Chem 271:1544-1550. (Pubitemid 26028643)
29. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G. 1996b. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 271:17124-17131. (Pubitemid 26244262)
30. Knauper V, Bailey L, Worley JR, Soloway P, Patterson ML, Murphy G. 2002. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13. FEBS Lett 532:127-130. (Pubitemid 35378666)
31. Krane SM, Inada M. 2008. Matrix metalloproteinases and bone. Bone 43:7-18.
32. Lee ER. 2006. Proteolytic enzymes in skeletal development: histochemical methods adapted to the study of matrix lysis during the transformation of a "cartilage model" into bone. Front Biosci 11:2538-2553.
33. Lee ER, Trasler J, Dwivedi S, Leblond CP. 1982. Divison of the mouse gastric mucosa into zymogenic and mucous regions on the basis of gland features. Am J Anat 164:187-207.
34. Lee ER, Lamplugh L, Leblond CP, Mordier S, Magny MC, Mort JS. 1998. Immunolocalization of the cleavage of the aggrecan core protein at the Asn341-Phe342 bond, as an indicator of the location of the metalloproteinases active in the lysis of the rat growth plate. Anat Rec 252:117-132. (Pubitemid 28397565)
35. Lee ER, Lamplugh L, Davoli MA, Beauchemin A, Chan K, Mort JS, Leblond CP. 2001. Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats ages 0-21 days: I. Two groups of proteinases cleave the core protein of aggrecan. Dev Dyn 222:52-70.
36. Lee ER, Lamplugh L, Kluczyk B, Mort JS, Leblond CP. 2006. Protease analysis by neoepitope approach reveals the activation of MMP-9 is achieved proteolytically in a test tissue cartilage model involved in bone formation. J Histochem Cytochem 54:965-980. (Pubitemid 44298583)
37. Madsen DH, Engelholm LH, Ingvarsen S, Hillig T, Wagenaar-Miller RA, Kjoller L, Gardsvoll H, Hoyer-Hansen G, Holmbeck K, Bugge TH, Behrendt N. 2007. Extracellular collagenases and the endocytic receptor, urokinase plasminogen activator receptor-associated protein/Endo180, cooperate in fibroblast-mediated collagen degradation. J Biol Chem 282:27037-27045. (Pubitemid 47501939)
38. Matyas JR, Atley L, Ionescu M, Eyre DR, Poole AR. 2004. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum 50:543-552. (Pubitemid 38198838)
39. McLean IW, Nakane PK. 1974. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem 22:1077-1083.
40. Miller EJ, Harris ED Jr, Chung E, Finch JE Jr, McCroskery PA, Butler WT. 1976. Cleavage of Type II and III collagens with mammalian collagenase: site of cleavage and primary structure at the NH2-terminal portion of the smaller fragment released from both collagens. Biochemistry 15:787-792.
41. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, Hambor JE. 1996. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97:761-768. (Pubitemid 26060542)
42. Mort JS, Buttle DJ. 1999. The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways. Mol Pathol 52:11-18. (Pubitemid 29064257)
43. Murphy G, Knauper V. 1997. Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol 15:511-518.
44. Murphy G, Nagase H. 2008. Progress in matrix metalloproteinase research. Mol Aspects Med.
45. Murphy G, Reynolds JJ, Bretz U, Baggiolini M. 1982. Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. Biochem J 203:209-221.
46. Murphy G, Knauper V, Cowell S, Hembry R, Stanton H, Butler G, Freije J, Pendas AM, Lopez-Otin C. 1999. Evaluation of some newer matrix metalloproteinases. Ann N Y Acad Sci 878:25-39. (Pubitemid 29353558)
47. Nagase H, Visse R, Murphy G. 2006. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562-573. (Pubitemid 43139720)
48. O'Kane JW, Hutchinson E, Atley LM, Eyre DR. 2006. Sport-related differences in biomarkers of bone resorption and cartilage degradation in endurance athletes. Osteoarthritis Cartilage 14:71-76. (Pubitemid 43034091)
49. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. 1997. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272:2446-2451. (Pubitemid 27058534)
50. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H. 1990. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 194:721-730.
51. Overall CM. 2002. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol Biotechnol 22:51-86.
52. Page-McCaw A, Ewald AJ, Werb Z. 2007. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221-233. (Pubitemid 46310551)
53. Patterson ML, Atkinson SJ, Knauper V, Murphy G. 2001. Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. FEBS Lett 503:158-162. (Pubitemid 32763197)
54. Ra HJ, Parks WC. 2007. Control of matrix metalloproteinase catalytic activity. Matrix Biol 26:587-596. (Pubitemid 350180394)
55. Roach HI, Clarke NM. 2000. Physiological cell death of chondrocytes in vivo is not confined to apoptosis. New observations on the mammalian growth plate. J Bone Joint Surg Br 82:601-613. (Pubitemid 30312832)
56. Roach HI, Baker JE, Clarke NM. 1998. Initiation of the bony epiphysis in long bones: chronology of interactions between the vascular system and the chondrocytes. J Bone Miner Res 13:950-961. (Pubitemid 28265273)
57. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IM, Liotta LA. 1989. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 264:1353-1356.
58. Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, Yu Y, Fosang AJ, Schorpp-Kistner M, Angel P, Werb Z. 2004. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131:5883-5895. (Pubitemid 40123905)
59. Wagenaar-Miller RA, Engelholm LH, Gavard J, Yamada SS, Gutkind JS, Behrendt N, Bugge TH, Holmbeck K. 2007. Complementary roles of intracellular and pericellular collagen degradation pathways in vivo. Mol Cell Biol 27:6309-6322. (Pubitemid 47435739)
60. Welgus HG, Jeffrey JJ, Stricklin GP, Roswit WT, Eisen AZ. 1980. Characteristics of the action of human skin fibroblast collagenase on fibrillar collagen. J Biol Chem 255:6806-6813. (Pubitemid 10014106)
61. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Cao Y, Tryggvason K. 2000. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A 97:4052-4057. (Pubitemid 30226085)